AIM: Handheld support system improves PE diagnosis

A handheld decision-support system may improve diagnostic decision making for patients with suspected pulmonary embolism (PE) in the emergency department, suggests a study published in the Nov. 17 online edition of the Annals of Internal Medicine.

Twenty emergency departments in France were part of the clinical study. Pierre-Marie Roy, MD, PhD, and colleagues from Centre Hospitalier Universitaire d'Angers and Université d'Angers in Angers, France, sought to assess the effectiveness of a handheld clinical decision support system to improve the diagnostic work-up of suspected PE among patients in the emergency department.

Testing for PE often differs from that recommended by evidence-based guidelines, according to Roy and colleagues.

The cluster randomized trial (providers were not blinded, outcome assessment was automated) involved a pre-intervention period involving 20 centers and 1,103 patients, in which providers grew accustomed to inputting clinical data into handheld devices and investigators assessed baseline testing.

After the pre-intervention period, 1,768 consecutive outpatients with suspected PE were assigned to randomly chosen emergency departments that activated a clinical decision support system on the devices (10 centers, 753 patients) or posters and pocket cards that showed validated diagnostic strategies (10 centers, 1,015 patients).

The appropriateness of diagnostic work-up, defined as any sequences of tests that yielded a post-test probably less than 5 percent or greater than 85 percent, and the number of tests per patient were measured.

The authors found that the proportion of patients who received appropriate diagnostic work-ups was greater during the trial than in the pre-intervention period in both groups. However, the increase was greater in the computer-based guidelines group. Among patients with appropriate work-ups, those in the computer-based guidelines group received slightly fewer tests than did patients in the paper guidelines groups.

According to the authors, the study was not designed to show a difference in the clinical outcomes of patients during follow-up.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.